Dr. Jean-Claude Dubacher Appointed Chairman and Chief Executive Officer of B. Braun of America Inc.

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

B. Braun Medical reports on June 1, 2020, Dr. Jean-Claude Dubacher succeeded Caroll H. Neubauer as Chairman and Chief Executive Officer of B. Braun of America Inc. Neubauer will continue as a Member of the Management Board of B. Braun SE and Executive Director of B. Braun of America Inc. until August 31, 2020.

Dr. Dubacher joined B. Braun in August 2019 as President, B. Braun Medical Inc., and became Chairman and Chief Executive Officer of B. Braun Medical Inc. on January 1, 2020.



Subscribe to Medical Device News Magazine

Related Articles